CareDx (CDNA) Asset Writedowns and Impairment (2021 - 2023)
CareDx's (CDNA) quarterly Asset Writedowns and Impairment came in at $1.0 million in Q1 2023, up 19.05% quarter-over-quarter from $840000.0 in Q3 2022.
Analysis
CareDx (CDNA) Asset Writedowns and Impairment (2021 - 2023) Analysis & Trends
CareDx has disclosed Asset Writedowns and Impairment across 3 years of filings, most recently posting $1.0 million for Q1 2023.
- In Q1 2023, Asset Writedowns and Impairment changed N/A year-over-year to $1.0 million; the TTM figure through Dec 2023 stood at $1.0 million (up 19.05% YoY), while the FY2025 annual figure was $2.3 million, changed N/A from the prior year.
- Asset Writedowns and Impairment came in at $1.0 million for Q1 2023 at CareDx, up from $840000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $2.4 million in Q4 2021 to a low of $840000.0 in Q3 2022.
- Average Asset Writedowns and Impairment over 3 years is $1.4 million, with a median of $1.0 million recorded in 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | CareDx | 2.77 Bn | 2.40 Bn | 116.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 1.00 Mn |
| Sep 30, 2022 | 840,000.00 |
| Dec 31, 2021 | 2.44 Mn |